Shanghai Nanhui Nanhua Hospital
1 clinical trials · Sponsor
◉ Watch Shanghai Nanhui Nanhua Hospital
| Record | Firm | Date |
|---|---|---|
| The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC (NCT03084250) | Shanghai Nanhui Nanhua Hospital | 2017-03-10 |
Track Shanghai Nanhui Nanhua Hospital automatically
Every clearance here is in the API, with alerts when new ones post.